A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management.
C. David Klingman, PhD
Advertisement
Articles by C. David Klingman, PhD
Advertisement
Latest Updated Articles
- Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients
Published: September 7th 2009 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Stereotactic Body Radiation Therapy Equally Effective as Surgery in Stage I NSCLC
3
Measles Outbreaks Cause Financial, Public Health Burden in US
4
New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access
5
